Cargando…
Early abiraterone acetate treatment is beneficial in Japanese castration-resistant prostate cancer after failure of primary combined androgen blockade
BACKGROUND: Development of novel agents targeting the androgen axis has led to improved overall survival in castration-resistant prostate cancer (CRPC). This study aimed to investigate the optimal timing of treatment with one such agent, abiraterone acetate (AA), in Japanese patients. MATERIALS AND...
Autores principales: | Nagai, Takashi, Naiki, Taku, Iida, Keitaro, Etani, Toshiki, Ando, Ryosuke, Hamamoto, Shuzo, Sugiyama, Yosuke, Akita, Hidetoshi, Kubota, Hiroki, Hashimoto, Yoshihiro, Kawai, Noriyasu, Yasui, Takahiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Asian Pacific Prostate Society
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5857185/ https://www.ncbi.nlm.nih.gov/pubmed/29556485 http://dx.doi.org/10.1016/j.prnil.2017.07.001 |
Ejemplares similares
-
A pilot study of gemcitabine and paclitaxel as third-line chemotherapy in
metastatic urothelial carcinoma
por: Naiki, Taku, et al.
Publicado: (2017) -
Laparoscopic radical surgery produces a good prognosis in an elderly patient with small Wilms’ tumor
por: Ota, Yuya, et al.
Publicado: (2019) -
Pure Lymphoepithelioma-Like Carcinoma Originating from the Urinary Bladder
por: Nagai, Takashi, et al.
Publicado: (2016) -
Gemcitabine and docetaxel as second-line chemotherapy in elderly patients with metastatic urothelial carcinoma: a retrospective analysis
por: Naiki, Taku, et al.
Publicado: (2018) -
Combination therapy with radiation and hyperthermia‐induced clinical complete response of small cell carcinoma of prostate
por: Kawai, Noriyasu, et al.
Publicado: (2022)